CapsoVision financials
$6.69−3.32%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 |
|---|---|
| Revenue | $13.6M |
| Gross profit | $7.2M |
| Gross margin | 52.9% |
| Operating income | -$25.5M |
| Net income | -$25.3M |
| Net margin | −186.8% |
| Diluted EPS | $-1.03 |
| EBITDA | -$24.9M |
| Operating cash flow | -$22.9M |
| Free cash flow | -$23.0M |
| Diluted shares | 24.6M |
Balance sheet
| Period end | Dec 31 |
|---|---|
| Cash & equivalents | $10.1M |
| Short-term investments | $0.00 |
| Total debt | $0.00 |
| Total assets | $18.2M |
| Total liabilities | $4.9M |
| Shareholders' equity | $13.3M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology